El Garch, H <br/><br/>
A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse.  [electronic resource] 

 -  Veterinary immunology and immunopathology  Jun 2008 
 - 230-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0165-2427 
<br/><br/><label>Standard No.: </label>10.1016/j.vetimm.2008.02.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antibodies, Viral--biosynthesis<br/>Enzyme-Linked Immunosorbent Assay--veterinary<br/>Female<br/>Horse Diseases--immunology<br/>Horses--immunology<br/>Immunization, Secondary--veterinary<br/>Interferon-gamma--blood<br/>Male<br/>Neutralization Tests--veterinary<br/>Statistics, Nonparametric<br/>Vaccination--methods<br/>Viral Vaccines--administration & dosage<br/>West Nile Fever--immunology<br/>West Nile Virus Vaccines--administration & dosage<br/>West Nile virus--immunology